Yahoo! Sports

ADCC Confirms First Batch of Invites For 2026 World Championships

The road to ADCC World Championship 2026 officially begins with the first wave of invited athletes and it starts at the very top. As tradition holds, the champions receive automatic invitations, ...
CNET

Strength Training for Beginners: How to Build a Workout Program That Will Make 2026 Your Strongest Year Yet

I'm a Fitness & Nutrition writer for CNET who enjoys reviewing the latest fitness gadgets, testing out activewear and sneakers, as well as debunking wellness/fitness myths. In my free time I enjoy ...
The New York Times

Researchers Are Using A.I. to Decode the Human Genome

AlphaGenome is a leap forward in the ability to study the human blueprint. But the fine workings of our DNA are still largely a mystery. By Carl Zimmer In 2024, two scientists from Google DeepMind ...
Hosted on MSN

Landen Fortunato vs Christian Hakobyan 2026 ADCC San Diego Open

Landen Fortunato vs Christian Hakobyan 2026 ADCC San Diego Open Trump says will require voter ID for midterms regardless of Congress US facing potential 'new housing crisis' Microsoft AI chief gives ...
Business Insider

Viewbix: Quantum Transportation Completes First Milestone in Transformer-Based Quantum Decoder Program, Securing Key IP License from Ramot at Tel Aviv University

Tel Aviv, Israel, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Viewbix Inc. (Nasdaq: VBIX) (“Viewbix” or the “Company”), an advanced technologies company, today ...
PGA Tour

How it works: PGA TOUR Returning Member Program

In response to fan research that shows a clear desire to see the best golfers competing together more often – as well as timely inquiries from players not currently competing on the PGA TOUR and ...
Seeking Alpha

CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response

Collaboration will engage leading transplant clinician-scientists to study antibody-mediated rejection (AMR) and microvascular inflammation (MVI) using cellular-resolution profiling CareDx will ...
The Bakersfield Californian

CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response

CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value ...
Rutland Herald

CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response

Insights generated from this program are intended to support future clinical diagnostic development. CareDx will leverage 10x’s Xenium spatial and Chromium Flex single cell platforms for this ...
Business Wire

CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response

Collaboration will engage leading transplant clinician-scientists to study antibody-mediated rejection (AMR) and microvascular inflammation (MVI) using cellular-resolution profiling BRISBANE, Calif.-- ...
Morningstar

CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response

Collaboration will engage leading transplant clinician-scientists to study antibody-mediated rejection (AMR) and microvascular inflammation (MVI) using cellular-resolution profiling CareDx, Inc.